Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth, Vascular | 28 | 1997 | 317 | 1.400 |
Why?
|
| Hypertension | 19 | 1997 | 1531 | 0.880 |
Why?
|
| Norepinephrine | 18 | 1997 | 276 | 0.630 |
Why?
|
| Blood Pressure | 21 | 1997 | 1447 | 0.480 |
Why?
|
| Eflornithine | 4 | 1997 | 15 | 0.450 |
Why?
|
| Rats | 37 | 1997 | 5300 | 0.390 |
Why?
|
| Polyamines | 3 | 1997 | 79 | 0.390 |
Why?
|
| Desoxycorticosterone | 8 | 1991 | 41 | 0.330 |
Why?
|
| Sodium Chloride | 8 | 1991 | 136 | 0.330 |
Why?
|
| Potassium Chloride | 12 | 1997 | 45 | 0.310 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 2 | 1997 | 7 | 0.310 |
Why?
|
| Aortic Coarctation | 2 | 1997 | 37 | 0.300 |
Why?
|
| Rats, Inbred Strains | 18 | 1992 | 532 | 0.300 |
Why?
|
| Muscle Contraction | 14 | 1997 | 210 | 0.290 |
Why?
|
| Vasoconstriction | 5 | 1993 | 81 | 0.290 |
Why?
|
| Aorta | 7 | 1997 | 316 | 0.290 |
Why?
|
| Angiotensin II | 6 | 1993 | 220 | 0.250 |
Why?
|
| Biphenyl Compounds | 3 | 1993 | 184 | 0.240 |
Why?
|
| Tetrazoles | 3 | 1993 | 160 | 0.240 |
Why?
|
| Imidazoles | 3 | 1993 | 175 | 0.240 |
Why?
|
| Enzyme Inhibitors | 2 | 1997 | 659 | 0.240 |
Why?
|
| Receptors, Adrenergic, alpha | 5 | 1996 | 40 | 0.220 |
Why?
|
| Animals | 37 | 1997 | 20877 | 0.210 |
Why?
|
| Hemodynamics | 3 | 1993 | 705 | 0.200 |
Why?
|
| Calcium | 7 | 1991 | 929 | 0.200 |
Why?
|
| Isoproterenol | 9 | 1988 | 163 | 0.190 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 3 | 1995 | 12 | 0.190 |
Why?
|
| Aging | 3 | 1992 | 911 | 0.180 |
Why?
|
| Receptors, Adrenergic, beta | 4 | 1991 | 153 | 0.180 |
Why?
|
| Clonidine | 4 | 1994 | 66 | 0.170 |
Why?
|
| Potassium | 3 | 1988 | 168 | 0.170 |
Why?
|
| Muscle Relaxation | 5 | 1997 | 31 | 0.160 |
Why?
|
| Cerebrovascular Circulation | 2 | 1993 | 296 | 0.160 |
Why?
|
| Sodium | 3 | 1987 | 161 | 0.160 |
Why?
|
| Ornithine Decarboxylase | 2 | 1994 | 17 | 0.150 |
Why?
|
| Serotonin | 3 | 1992 | 144 | 0.140 |
Why?
|
| Male | 34 | 1997 | 37281 | 0.140 |
Why?
|
| Phentolamine | 2 | 1986 | 8 | 0.140 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 1993 | 155 | 0.130 |
Why?
|
| Rats, Inbred SHR | 6 | 1994 | 95 | 0.130 |
Why?
|
| Biogenic Polyamines | 1 | 1994 | 8 | 0.130 |
Why?
|
| In Vitro Techniques | 9 | 1997 | 765 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 8 | 1997 | 2083 | 0.120 |
Why?
|
| Blood Vessels | 1 | 1994 | 102 | 0.120 |
Why?
|
| Femoral Artery | 7 | 1987 | 139 | 0.120 |
Why?
|
| Verapamil | 1 | 1993 | 30 | 0.110 |
Why?
|
| Sodium Chloride, Dietary | 1 | 1993 | 50 | 0.110 |
Why?
|
| Hydralazine | 2 | 1993 | 12 | 0.110 |
Why?
|
| Benzylamines | 1 | 1991 | 28 | 0.100 |
Why?
|
| Neurotoxins | 1 | 1991 | 30 | 0.100 |
Why?
|
| Ion Channels | 2 | 1987 | 72 | 0.090 |
Why?
|
| Nitroprusside | 4 | 1997 | 42 | 0.090 |
Why?
|
| Acetylcholine | 4 | 1997 | 64 | 0.090 |
Why?
|
| Adipose Tissue | 1 | 1991 | 221 | 0.090 |
Why?
|
| Vascular Resistance | 2 | 1993 | 179 | 0.080 |
Why?
|
| Phenylephrine | 4 | 1994 | 61 | 0.080 |
Why?
|
| Electric Stimulation | 3 | 1994 | 218 | 0.080 |
Why?
|
| Sympathetic Nervous System | 2 | 1985 | 81 | 0.080 |
Why?
|
| Heart Rate | 4 | 1993 | 568 | 0.080 |
Why?
|
| Hydrochlorothiazide | 1 | 1987 | 15 | 0.080 |
Why?
|
| Basilar Artery | 1 | 1987 | 38 | 0.070 |
Why?
|
| Organ Size | 3 | 1991 | 242 | 0.070 |
Why?
|
| Cerebrovascular Disorders | 1 | 1987 | 182 | 0.070 |
Why?
|
| Arteries | 3 | 1997 | 108 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1991 | 1745 | 0.070 |
Why?
|
| Vasodilator Agents | 3 | 1997 | 138 | 0.070 |
Why?
|
| Diet | 4 | 1991 | 513 | 0.070 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 1985 | 45 | 0.060 |
Why?
|
| Losartan | 3 | 1993 | 45 | 0.060 |
Why?
|
| Rats, Inbred WKY | 3 | 1993 | 48 | 0.060 |
Why?
|
| Receptors, Adrenergic | 1 | 1984 | 68 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 2 | 1997 | 107 | 0.060 |
Why?
|
| Vasodilation | 2 | 1996 | 85 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1985 | 154 | 0.060 |
Why?
|
| Body Weight | 4 | 1993 | 554 | 0.060 |
Why?
|
| Prazosin | 2 | 1993 | 10 | 0.060 |
Why?
|
| Time Factors | 5 | 1996 | 4655 | 0.050 |
Why?
|
| Aorta, Thoracic | 4 | 1996 | 211 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 1996 | 371 | 0.050 |
Why?
|
| Epinephrine | 2 | 1992 | 103 | 0.040 |
Why?
|
| Thiazolidinediones | 1 | 1997 | 76 | 0.040 |
Why?
|
| Hyperplasia | 1 | 1997 | 89 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 1997 | 189 | 0.040 |
Why?
|
| Laminin | 1 | 1997 | 62 | 0.040 |
Why?
|
| Fibronectins | 1 | 1997 | 130 | 0.040 |
Why?
|
| Aorta, Abdominal | 1 | 1997 | 97 | 0.040 |
Why?
|
| Tail | 2 | 1997 | 8 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 1996 | 99 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1997 | 140 | 0.030 |
Why?
|
| Sodium Nitrite | 2 | 1986 | 2 | 0.030 |
Why?
|
| Oligopeptides | 1 | 1996 | 152 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 2 | 1994 | 32 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1994 | 57 | 0.030 |
Why?
|
| Guanidines | 1 | 1994 | 32 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 1997 | 361 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1174 | 0.030 |
Why?
|
| Consciousness | 1 | 1993 | 17 | 0.030 |
Why?
|
| Mesenteric Arteries | 1 | 1993 | 29 | 0.030 |
Why?
|
| Hindlimb | 1 | 1993 | 38 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 1995 | 1663 | 0.030 |
Why?
|
| Weaning | 1 | 1993 | 12 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1993 | 223 | 0.030 |
Why?
|
| Monocrotaline | 1 | 1992 | 4 | 0.030 |
Why?
|
| Calcitonin | 1 | 1991 | 21 | 0.030 |
Why?
|
| Methoxamine | 1 | 1991 | 3 | 0.030 |
Why?
|
| Phenoxybenzamine | 1 | 1991 | 7 | 0.030 |
Why?
|
| Putrescine | 1 | 1991 | 17 | 0.030 |
Why?
|
| Spermidine | 1 | 1991 | 21 | 0.030 |
Why?
|
| Dioxanes | 1 | 1991 | 15 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1991 | 165 | 0.030 |
Why?
|
| Spermine | 1 | 1991 | 49 | 0.030 |
Why?
|
| 1-Sarcosine-8-Isoleucine Angiotensin II | 1 | 1991 | 5 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 1991 | 14 | 0.020 |
Why?
|
| Histological Techniques | 1 | 1991 | 10 | 0.020 |
Why?
|
| Nephrectomy | 1 | 1991 | 103 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1991 | 145 | 0.020 |
Why?
|
| Myocardium | 1 | 1997 | 1204 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 1994 | 497 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 1992 | 232 | 0.020 |
Why?
|
| Kinetics | 1 | 1991 | 1047 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1993 | 1753 | 0.020 |
Why?
|
| Calcimycin | 1 | 1987 | 32 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1993 | 1329 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1991 | 785 | 0.020 |
Why?
|
| Rubidium | 1 | 1986 | 2 | 0.020 |
Why?
|
| Calcium Chloride | 1 | 1986 | 38 | 0.020 |
Why?
|
| Radioisotopes | 1 | 1986 | 40 | 0.020 |
Why?
|
| Biological Transport | 1 | 1987 | 210 | 0.020 |
Why?
|
| Heart | 1 | 1991 | 850 | 0.020 |
Why?
|
| Extracellular Space | 1 | 1986 | 121 | 0.020 |
Why?
|
| Kidney | 1 | 1991 | 945 | 0.020 |
Why?
|
| Species Specificity | 1 | 1986 | 302 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 357 | 0.020 |
Why?
|
| Doxepin | 1 | 1985 | 5 | 0.020 |
Why?
|
| Imipramine | 1 | 1985 | 44 | 0.020 |
Why?
|
| Ligation | 1 | 1984 | 83 | 0.010 |
Why?
|
| Iliac Artery | 1 | 1984 | 44 | 0.010 |
Why?
|
| Gestational Age | 1 | 1985 | 389 | 0.010 |
Why?
|
| Protein Binding | 2 | 1996 | 1027 | 0.010 |
Why?
|
| Female | 4 | 1991 | 38015 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1988 | 2550 | 0.010 |
Why?
|
| Pregnancy | 1 | 1985 | 2331 | 0.010 |
Why?
|
| Glyburide | 1 | 1997 | 19 | 0.010 |
Why?
|
| Metformin | 1 | 1997 | 63 | 0.010 |
Why?
|
| Thiazoles | 1 | 1997 | 95 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1997 | 371 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1996 | 164 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1996 | 9 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1996 | 53 | 0.010 |
Why?
|
| Cricetinae | 1 | 1995 | 262 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1996 | 231 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1994 | 89 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1994 | 109 | 0.010 |
Why?
|
| Adrenergic alpha-1 Receptor Antagonists | 1 | 1994 | 20 | 0.010 |
Why?
|
| Insulin | 1 | 1997 | 617 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1994 | 201 | 0.010 |
Why?
|
| Piperazines | 1 | 1995 | 206 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 1082 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 420 | 0.010 |
Why?
|
| Pressoreceptors | 1 | 1992 | 15 | 0.010 |
Why?
|
| Renin | 1 | 1992 | 96 | 0.010 |
Why?
|
| Pharmaceutical Vehicles | 1 | 1991 | 5 | 0.010 |
Why?
|
| Ovariectomy | 1 | 1991 | 49 | 0.010 |
Why?
|
| Bone Development | 1 | 1991 | 37 | 0.010 |
Why?
|
| Tibia | 1 | 1991 | 93 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1996 | 2688 | 0.000 |
Why?
|
| Humans | 2 | 1997 | 68525 | 0.000 |
Why?
|